A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 163 participants.
Also called NCT01742585
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 163 participants
- Sponsor
- Registry
-
NCT01742585
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01742585. Randomized; quadruple masking; primary purpose treatment. Start 2012-10 (registry gives no type); primary completion 2014-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis
- Condition
- Chronic Kidney Disease
- Condition
- Renal Insufficiency
- Condition
- Hyperphosphatemia
- Intervention (Drug)
- ASP1585
- Intervention (Drug)
- placebo
- Lead sponsor
- Astellas Pharma Inc
Record details
- Record id
cardio:ct-nct01742585- Content hash
a0744ddec1bc6bca723ccd21e3f9650a37e0b5ffb3acf32136c6735e8330bba6